Formed by some heavy-weights in ageing research: David Sinclair, Steve Horvath, Juan Carlos Izpisua Belmonte, and Manuel Serrano.

Planning cellular reprogramming clinical trial in 2020.

Iduna Therapeutics is developing epigenetic reprogramming therapies that allow the rejuvenation and replacement of tissues that cannot regenerate themselves after injury or degeneration. This could permit regeneration without external tissue or surgery. David Sinclair, Steve Horvath, Juan Carlos Izpisua Belmonte, and Manuel Serrano are contributing to this effort.